CONFLICT OF INTEREST STATEMENT Michael R. Sperling has consulted for Medtronic and Neurelis. He has received research support from Medtronic, SK Life Science, Takeda, Xenon, Cerevel, UCB Pharma, Janssen, Equilibre, Epiwatch, Byteflies, Biohaven, Cavion, and Supernus. He has received royalties from Oxford University Press and Cambridge University Press. Itai Loushy has no conflicts of interest to declare.